Literature DB >> 18338250

Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A.

Xin-An Liu1, Ling-Qiang Zhu, Qi Zhang, Hai-Rong Shi, Shao-Hui Wang, Qun Wang, Jian-Zhi Wang.   

Abstract

Protein kinase A (PKA) plays a crucial role in tau hyperphosphorylation, an early event of Alzheimer disease (AD), and 17beta-estradiol replacement in aging women forestalls the onset of AD. However, the role of estradiol in PKA-induced tau hyperphosphorylation is not known. Here, we investigated the effect of 17beta-estradiol on cAMP/PKA activity and the PKA-induced tau hyperphosphorylation in HEK293 cells stably expressing tau441. We found that 17beta-estradiol effectively attenuated forskolin-induced overactivation of PKA and elevation of cAMP, and thus prevented tau from hyperphosphorylation. These data provide the first evidence that 17beta-estradiol can inhibit PKA overactivation and the PKA-induced tau hyperphosphorylation, implying a preventive role of 17beta-estradiol in AD-like tau pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18338250     DOI: 10.1007/s11064-008-9638-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  55 in total

1.  Estradiol induces PKA activation through the putative membrane receptor in the living hippocampal neuron.

Authors:  A S Shingo; S Kito
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

2.  Alzheimer's disease in women.

Authors:  C M Filley
Journal:  Am J Obstet Gynecol       Date:  1997-01       Impact factor: 8.661

3.  PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners.

Authors:  Fei Liu; Zhihou Liang; Jianhua Shi; Dongmei Yin; Ezzat El-Akkad; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2006-10-24       Impact factor: 4.124

4.  Protein serine/threonine phosphatase 2A activity is inhibited by cAMP in MA-10 cells.

Authors:  Cecilia Poderoso; Cristina Paz; Alejandra Gorostizaga; Fabiana Cornejo Maciel; Carlos F Mendez; Ernesto J Podesta
Journal:  Endocr Res       Date:  2002-11       Impact factor: 1.720

5.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

6.  A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology.

Authors:  Y Zhang; H-L Li; D-L Wang; S-J Liu; J-Z Wang
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

Review 7.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

8.  Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3.

Authors:  T J Singh; N Haque; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

9.  Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus.

Authors:  P Cardona-Gomez; M Perez; J Avila; L M Garcia-Segura; F Wandosell
Journal:  Mol Cell Neurosci       Date:  2004-03       Impact factor: 4.314

10.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  23 in total

1.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

Review 2.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

3.  Ovariectomy increases the age-induced hyperphosphorylation of Tau at hippocampal CA1.

Authors:  O Picazo; J Espinosa-Raya; A Briones-Aranda; M Cerbón
Journal:  Cogn Process       Date:  2016-06-08

4.  Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.

Authors:  Qing-Guo Ren; Yan-Juan Wang; Wei-Gang Gong; Qi-Da Zhou; Lin Xu; Zhi-Jun Zhang
Journal:  J Mol Neurosci       Date:  2015-02-17       Impact factor: 3.444

5.  Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.

Authors:  Emily R Rosario; Jenna Carroll; Christian J Pike
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

6.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 7.  Targeting estrogen receptors for the treatment of Alzheimer's disease.

Authors:  Jung Hoon Lee; Yanxialei Jiang; Dong Hoon Han; Seung Kyun Shin; Won Hoon Choi; Min Jae Lee
Journal:  Mol Neurobiol       Date:  2013-06-16       Impact factor: 5.590

Review 8.  Non-feminizing estrogens: a novel neuroprotective therapy.

Authors:  Ashley B Petrone; Joshua W Gatson; James W Simpkins; Miranda N Reed
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

Review 9.  Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.

Authors:  Mrinmay Chakrabarti; Azizul Haque; Naren L Banik; Prakash Nagarkatti; Mitzi Nagarkatti; Swapan K Ray
Journal:  Brain Res Bull       Date:  2014-09-20       Impact factor: 4.077

10.  Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.

Authors:  Lindsey A Smith; Lori L McMahon
Journal:  Neurobiol Dis       Date:  2017-12-01       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.